This document, however, is not a simple recitation of quarterly earnings. It is, rather, a tentative cartography of the firm’s current disposition, a fragment recovered from the hypothetical ‘Codex Mercatorum’ – a compendium of financial entities and their ever-shifting fortunes.
U.S. equities generally decided they needed a sit-down on Tuesday, with selling pressure building up like a very impatient queue. The Dow, in its infinite wisdom, decided to lead the charge downwards, tumbling 870.74 points to 48,488.59. The Nasdaq Composite followed suit, dropping 561.06 points to 22,954.32, while the S&P 500 and NYSE Composite also joined the party, losing points with a sort of resigned sigh. It was, in short, a day where nobody won, which is statistically quite likely, actually.
These are not companies that innovate so much as they adapt. They do not seek to create needs, but to satisfy existing ones, and to do so at a price point that discourages resistance. Competition, in their respective sectors, is not so much defeated as quietly absorbed or rendered irrelevant. Coca-Cola doesn’t merely sell a beverage; it sells a habit. Costco and Walmart offer not simply goods, but a calculated convenience. It is a system, and systems, once established, are notoriously difficult to dismantle.
Amazon, a name now synonymous with the very act of commerce, and Hims & Hers Health, a younger, more audacious claimant to the affections of a digitally native generation, both present themselves as worthy of continued investment. Whether they truly merit such faith is a question demanding a more nuanced consideration than is typically afforded in the prevailing atmosphere of speculative enthusiasm.
monthly – a veritable flood of income, designed, no doubt, to encourage a life of comfortable idleness. They claim a yield of some 5.2%, a figure which, while not extravagant, is sufficient to maintain a modest establishment, or perhaps indulge in a particularly fine vintage.
Junaid Siddiqui of Truist Securities – a name which, one suspects, is merely a clever disguise for a committee of very serious accountants2 – lowered his price target on Commvault. He now believes the stock is worth $175 per share, a reduction of $35 from his previous estimation. A considerable sum, of course, though less than the cost of a decent goblin-forged filing cabinet. He did, however, maintain his ‘buy’ recommendation, which is a bit like advising someone to jump into a slightly chilly pond – not ideal, but not immediately life-threatening.
It appears Iamgold managed to wrestle 765,900 ounces of gold from the earth in the last cycle1. A respectable haul, particularly given the increasingly grumpy disposition of the earth itself. Production at their Essakane, Côté, and Westwood sites was, shall we say, enthusiastic. 117,300, 87,200, and 37,900 attributable ounces respectively. One wonders if they’re offering hazard pay to the gnomes responsible for the extraction.
The proximate cause, as near as one can discern, is the President’s renewed interest in acquiring Greenland. One trusts the feasibility studies were conducted with the same rigor applied to, say, a balanced budget. Oklo, naturally, found itself swept along in the resulting turbulence. The notion that a company building nuclear reactors is vulnerable to the whims of geopolitical posturing is, of course, a commentary on the age.
Three years have passed, and the stock has multiplied in value by a factor that borders on the fantastical—a surge of 2,400%. Its market capitalization, exceeding $400 billion, places it amongst the titans of industry, a position earned, perhaps, more through prevailing sentiment than immutable worth. It stands now, a somewhat improbable edifice, built upon the shifting sands of expectation.
Conagra, you see, isn’t exactly setting the world on fire. They make perfectly acceptable food, the kind you eat when you’re exhausted and have given up on pretending to be a grown-up. But they don’t lead in anything. PepsiCo, for example, doesn’t dominate cola, and yet, they’re still churning out profits. It’s a mystery to me. Maybe it’s the sheer volume. Or maybe it’s a conspiracy involving high fructose corn syrup and the manipulation of our collective sweet tooth. Anyway, Conagra’s latest earnings report was…less than inspiring. A 6.8% sales decline, organic sales down 3%. And then, the kicker: a $940 million impairment charge. It’s like admitting your brands aren’t worth what you thought. It’s the financial equivalent of realizing your childhood baseball cards are just…cards.